In May 2010, the haemorrhoid treatments and dermatological medicines containing the ingredient bufexamac were withdrawn from the German market. The Federal Institute for Drugs and Medical Devices in Germany decided that the ingredient has more side effects in comparison to positive benefits since it has caused allergic reactions in a number of patients.

Euromonitor International's Medicated Skin Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Medicated Skin Care market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Medicated Skin Care in Germany
Euromonitor International
April 2011
List of Contents and Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Category Data
- Bayer Vital GmbH in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 1 Bayer Vital GmbH: Key Facts
Summary 2 Bayer Vital GmbH: Operational Indicators
- Company Background
- Production
Summary 3 Bayer Vital AG: Production Statistics 2010
- Competitive Positioning
Summary 4 Bayer Vital GmbH: Competitive Position 2010
- Beiersdorf AG in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 5 Beiersdorf AG: Key Facts
Summary 6 Beiersdorf AG: Operational Indicators
- Company Background
- Production
Summary 7 Beiersdorf AG: Production Statistics 2010
- Competitive Positioning
Summary 8 Beiersdorf AG: Competitive Position 2010
- Boehringer Ingelheim Pharma GmbH & Co Kg in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
- Company Background
- Production
Summary 11 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2010
- Competitive Positioning
Summary 12 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2010
- GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 13 GlaxoSmithKline GmbH & Co KG: Key Facts
Summary 14 GlaxoSmithKline GmbH & Co KG: Operational Indicators
- Company Background
- Production
Summary 15 GlaxoSmithKline GmbH & Co KG: Production Statistics 2010
- Competitive Positioning
Summary 16 GlaxoSmithKline GmbH & Co KG: Competitive Position 2010
- Ratiopharm GmbH & Co in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 17 Ratiopharm GmbH & Co: Key Facts
Summary 18 Ratiopharm GmbH & Co: Operational Indicators
- Company Background
- Production
Summary 19 Ratiopharm GmbH & Co: Production Statistics 2010
- Competitive Positioning
Summary 20 Ratiopharm GmbH & Co: Competitive Position 2010
- Stada Arzneimittel AG in Consumer Health (germany)
- Strategic Direction
- Key Facts
Summary 21 STADA Arzneimittel AG: Key Facts
Summary 22 STADA Arzneimittel AG: Operational Indicators
- Company Background
- Production
Summary 23 STADA Arzneimittel AG: Production Statistics 2010
- Competitive Positioning
Summary 24 STADA Arzneimittel AG: Competitive Position 2010
- Executive Summary
- Consumer Health in Germany Stagnated in 2010
- the Health and Wellness Trend Is Having A Negative Impact on Consumer Health Sales
- Bayer Vital GmbH Remains the Leading Manufacturer of Consumer Health Products in Germany
- Chemists/pharmacies Continues To Be the Most Common Outlet for Consumer Health Products
- Consumer Health Sales Value Is Predicted To Decline During the Forecast Period
- Key Trends and Developments
- Increased Interest in Health and Wellness Leads To A Slowdown in OTC Sales
- Consumer Health Sales Through Internet Retailing Are Becoming Increasingly Popular
- Consumer Insecurities Affect the Consumer Health Category
- Innovation Is Key for the Survival of Premium Brands
- Self-medication in Germany
- Market Indicators
- Market Data
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventative Medicine
Summary 25 OTC Healthcare Switches 2008-2010
- Definitions
- Sources
Summary 26 Research Sources
List of Tables
- Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010
- Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
- Table 3 Acne Treatments by Format: % Value Breakdown 2005-2010
- Table 4 Medicated Skin Care Company Shares by Value 2006-2010
- Table 5 Medicated Skin Care Brand Shares by Value 2007-2010
- Table 6 Acne Treatments Brand Shares by Value 2007-2010
- Table 7 Hair Loss Treatments Brand Shares by Value 2007-2010
- Table 8 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
- Table 9 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015
- Table 10 Consumer Expenditure on Health Goods and Medical Services 2005-2010
- Table 11 Life Expectancy at Birth 2005-2010
- Table 12 Sales of Consumer Health by Category: Value 2005-2010
- Table 13 Sales of Consumer Health by Category: % Value Growth 2005-2010
- Table 14 Consumer Health Company Shares by Value 2006-2010
- Table 15 Consumer Health Brand Shares by Value 2007-2010
- Table 16 Penetration of Private Label by Category 2005-2010
- Table 17 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
- Table 18 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
- Table 19 Forecast Sales of Consumer Health by Category: Value 2010-2015
- Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

Pharmaceutical Market Research

Medicated Skin Care in Germany

Medicated Skin Care in Germany

Why buy this report?

Contents

Related products